314 related articles for article (PubMed ID: 32949986)
1. Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib).
Al-Khatib SM; Pokorney SD; Al-Khalidi HR; Haynes K; Garcia C; Martin D; Goldsack JC; Harkins T; Cocoros NM; Lin ND; Lipowicz H; McCall D; Nair V; Parlett L; McMahill-Walraven CN; Platt R; Granger CB
Am Heart J; 2020 Nov; 229():110-117. PubMed ID: 32949986
[TBL] [Abstract][Full Text] [Related]
2. Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.
Pokorney SD; Cocoros N; Al-Khalidi HR; Haynes K; Li S; Al-Khatib SM; Corrigan-Curay J; Driscoll MR; Garcia C; Calvert SB; Harkins T; Jin R; Knecht D; Levenson M; Lin ND; Martin D; McCall D; McMahill-Walraven C; Nair V; Parlett L; Petrone A; Temple R; Zhang R; Zhou Y; Platt R; Granger CB
JAMA Netw Open; 2022 May; 5(5):e2214321. PubMed ID: 35639381
[TBL] [Abstract][Full Text] [Related]
3. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
[TBL] [Abstract][Full Text] [Related]
4. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
Shantsila E; Wolff A; Lip GY; Lane DA
Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
[TBL] [Abstract][Full Text] [Related]
5. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
[TBL] [Abstract][Full Text] [Related]
6. Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.
Durham TA; Hassmiller Lich K; Viera AJ; Fine JP; Mukherjee J; Weinberger M; Dusetzina SB
Am J Cardiol; 2017 Nov; 120(10):1820-1829. PubMed ID: 28867127
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR
Thompson LE; Maddox TM; Lei L; Grunwald GK; Bradley SM; Peterson PN; Masoudi FA; Turchin A; Song Y; Doros G; Davis MB; Daugherty SL
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724655
[TBL] [Abstract][Full Text] [Related]
8. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk.
Lubitz SA; Khurshid S; Weng LC; Doros G; Keach JW; Gao Q; Gehi AK; Hsu JC; Reynolds MR; Turakhia MP; Maddox TM
Am Heart J; 2018 Jun; 200():24-31. PubMed ID: 29898845
[TBL] [Abstract][Full Text] [Related]
9. Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Tuan TC; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Hsieh MH; Lip GY; Chen SA
Mayo Clin Proc; 2016 May; 91(5):567-74. PubMed ID: 27068667
[TBL] [Abstract][Full Text] [Related]
10. Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population.
Willey V; Franchino-Elder J; Fu AC; Wang C; Sander S; Tan H; Kraft E; Jain R
BMJ Open; 2018 Jun; 8(6):e020676. PubMed ID: 29961012
[TBL] [Abstract][Full Text] [Related]
11. Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.
Hsu JC; Freeman JV
Clin Pharmacol Ther; 2018 Aug; 104(2):301-310. PubMed ID: 29328506
[TBL] [Abstract][Full Text] [Related]
12. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
[TBL] [Abstract][Full Text] [Related]
13. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
14. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
[TBL] [Abstract][Full Text] [Related]
15. Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke.
Redfors B; Gray WA; Lee RJ; Ellenbogen KA; Bonafede M; Ben-Yehuda O
JACC Clin Electrophysiol; 2017 Dec; 3(12):1369-1376. PubMed ID: 29759666
[TBL] [Abstract][Full Text] [Related]
16. Treatment with oral anticoagulant drugs restrained from patients with atrial fibrillation: An assessment in a geographically well-defined catchment area.
Andersson P; Löndahl M
Eur J Prev Cardiol; 2016 Sep; 23(13):1437-43. PubMed ID: 26976847
[TBL] [Abstract][Full Text] [Related]
17. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
[TBL] [Abstract][Full Text] [Related]
18. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
[TBL] [Abstract][Full Text] [Related]
19. Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis.
Grymonprez M; Steurbaut S; De Sutter A; Lahousse L
Open Heart; 2020 Dec; 7(2):. PubMed ID: 33361315
[TBL] [Abstract][Full Text] [Related]
20. Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: cross-sectional population database study.
Dreischulte T; Barnett K; Madhok V; Guthrie B
Eur J Gen Pract; 2014 Sep; 20(3):181-9. PubMed ID: 24351017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
